# Paraoxonase-1 activity and AOPP levels in patients with type 2 diabetes mellitus

## TL;DR

This study found that type 2 diabetes patients have lower antioxidant enzyme activity and higher protein damage markers compared to healthy individuals.

## Contribution

The study identifies PON1 activity and AOPP concentration as potential biomarkers for type 2 diabetes and their association with disease progression.

## Key findings

- Diabetic patients had significantly lower PON1 activity and higher AOPP levels compared to controls.
- AOPP concentration strongly correlated with diabetes-related biochemical parameters like HbA1c and LDL-C.
- AOPP at >340 mmol/L predicted diabetes with high sensitivity and specificity.

## Abstract

Paraoxonase 1 (PON1) is a calcium-dependent esterase and exerts antioxidant and antiatherogenic properties. Advanced oxidation protein products (AOPP) are a group of carbonylated protein products showing oxidant-mediated protein damage. This study aimed to determine serum PON1 activities and AOPP concentrations in diabetic patients and to evaluate these parameters in terms of their relationships with diabetes mellitus (DM) and related factors.

A total of 93 patients diagnosed with type 2 DM and 30 healthy controls were enrolled in the study. Serum AOPP levels and PON1 activities were measured spectrophotometrically. Other biochemical parameters, including glucose, total cholesterol, HDL-C, LDL-C, triglycerides, HbA1c and clinical/demographic data, were measured in the routine blood chemistry laboratory and retrieved from patient files.

Serum PON1 activity was significantly lower in patients with DM (31.6 [21.49-48.45] U/mL) compared to controls (41.08 [29.07-54.35] U/mL) (p= 0.028). Serum AOPP concentration was significantly higher in diabetic patients (584.6 [453.8-778.6] pmol/L) than in controls (173.9 [98.77-224.1] pmol/L) (p< 0.001). PON1 activity negatively correlated with AOPP concentration and positively with serum HDL-1 levels. AOPP concentration positively correlated with age, weight, HbA1c, glucose, total cholesterol, and LDL-C. A PON1 activity cut-off of ^25 U/mL predicted DM with a sensitivity of 36.56% and specificity of 90% (AUC: 0.634, p= 0.028). An AOPP concentration cut-off of >340 mmol/L predicted DM with a sensitivity of 89.25% and specificity of 93.33% (AUC: 0.965). Both PON1 (OR: 10.821, 95% CI: 1.959-59.778, p= 0.006) and AOPP (OR: 190.068, 95% CI: 20.102-1797.148, p< 0.001) were independently associated with DM after adjusting for age, sex, and weight.

AOPP and PON1 may play a significant role in the development and progression of DM. In particular, serum AOPP concentrations appear to be distinctive among patients with new-onset DM.